Anurag Kanase

Mr. Anurag Kanase

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2020 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
Ajay Vikram SinghAjay Vikram Singh
Ajay Vikram Singh
Mohammad Hasan Dad AnsariMohammad Hasan Dad Ansari
Mohammad Hasan Dad Ansari
DRDaniel Rosenkranz
Daniel Rosenkranz
RMRomi Singh Maharjan
Romi Singh Maharjan
FKFabian L. Kriegel
Fabian L. Kriegel
ALAndreas Luch
Andreas Luch
Advances in nanomedicine, coupled with novel methods of creating advanced materials at the nanoscale, have opened new perspectives for the development of healthcare and medical products. Special attention must be paid toward safe design approaches for nanomaterial‐based products. Recently, artificial intelligence (AI) and machine learning (ML) gifted the computational tool for enhancing and improving the simulation and modeling process for nanotoxicology and nanotherapeutics. In particular, the correlation of in vitro generated pharmacokinetics and pharmacodynamics to in vivo application scenarios is an important step toward the development of safe nanomedicinal products. This review portrays how in vitro and in vivo datasets are used in in silico models to unlock and empower nanomedicine. Physiologically based pharmacokinetic (PBPK) modeling and absorption, distribution, metabolism, and excretion (ADME)‐based in silico methods along with dosimetry models as a focus area for nanomedicine are mainly described. The computational OMICS, colloidal particle determination, and algorithms to establish dosimetry for inhalation toxicology, and quantitative structure–activity relationships at nanoscale (nano‐QSAR) are revisited. The challenges and opportunities facing the blind spots in nanotoxicology in this computationally dominated era are highlighted as the future to accelerate nanomedicine clinical translation.

20 February 2018 in Veins and Lymphatics
Verified
Journal Article
Open access
PDF file
Ajay Vikram SinghAjay Vikram Singh
Ajay Vikram Singh
Donato GemmatiDonato Gemmati
Donato Gemmati
AKAnurag Kanase
Anurag Kanase
IPIshan Pandey
Ishan Pandey
VMVatsala Misra
Vatsala Misra
JBJoachim Bill
Joachim Bill
Nanobiomaterials application into tissue repair and ulcer management is experiencing its golden age due to spurring diversity of translational opportunity to clinics. Over the past years, research in clinical science has seen a dramatic increase in medicinal materials at nanoscale those significantly contributed to tissue repair. This chapter outlines the new biomaterials at nanoscale those contribute state of the art clinical practices in ulcer management and wound healing due to their superior properties over traditional dressing materials. Designing new recipes for nanobiomaterials for tissue engineering practices spanning from micro to nano-dimension provided an edge over traditional wound care materials those mimic tissue in vivo. Clinical science stepped into design of artificial skin and extracellular matrix components emulating the innate structures with higher degree of precision. Advances in materials sciences polymer chemistry have yielded an entire class of new nanobiomaterials ranging from dendrimer to novel electrospun polymer with biodegradable chemistries and controlled molecular compositions assisting wound healing adhesives, bandages and controlled of therapeutics in specialized wound care. Moreover, supportive regenerative medicine is transforming into rational, real and successful component of modern clinics providing viable cell therapy of tissue remodeling. Soft nanotechnology involving hydrogel scaffold revolutionized the wound management supplementing physicobiochemical and mechanical considerations of tissue regeneration. Moreover, this chapter also reviews the current challenges and opportunities in specialized nanobiomaterials formulations those are desirable for optimal localized wound care considering their in situ physiological microenvironment.

5 August 2020 in Coatings
Verified
Journal Article
Open access
PDF file
APAprajita Tiwari Pandey
Aprajita Tiwari Pandey
IPIshan Pandey
Ishan Pandey
Paolo ZamboniPaolo Zamboni
Paolo Zamboni
Donato GemmatiDonato Gemmati
Donato Gemmati
AKAnurag Kanase
Anurag Kanase
Mohan Prasad SinghMohan Prasad Singh
Mohan Prasad Singh
Co-infection in patients with viral infection as a predisposing factor is less focused on during epidemic outbreaks, resulting in increased morbidity and mortality. Recent studies showed that patients with coronavirus disease 2019 (COVID-19) often have both bacterial and fungal co-infections. In this study, sputum samples of 120 OPD (outdoor patients) suffering from respiratory tract infection (RTI) but negative for tuberculosis infection were collected with informed consent. Morphological, biochemical, and resistance criteria were used to classify isolates and to distinguish multidrug resistant (MDR) isolates, which were further classified on a molecular basis. We found that the isolates, including MDR strains, showed remarkable sensitivity against acetone and methanol extracts of Moringa oleifera, Adhatoda vasica, and Cassia fistula. The results strongly confirmed that multifactorial infections can produce MDR characteristics against antimicrobial drugs, which gave insight into the use of herbal drugs with their age-old traditional importance as having antiviral, antibacterial, antifungal, anti-inflammatory, and immunomodulatory effects. We conclude that apart from this, the anti-infective potential of these plants can be used in the future in the form of products such as cosmetics, pharmaceutical coatings, surface coatings, drug delivery vehicle coatings, and other bioengineered coatings for public use. Future studies are required to assess therapeutics for co-infective resistant strains and nosocomial infections with immune-enhancing effects, thereby promoting their function in holistic treatment and therapy of COVID-19 patients.

7 May 2019 in AIP Conference Proceedings
Verified
Conference Paper
Closed access
PDF file
SWSandip Wadhai
Sandip Wadhai
AKAnurag Kanase
Anurag Kanase
RDRajashree Deokar
Rajashree Deokar
PYPranjali Yedewar
Pranjali Yedewar
ABArun Banpurkar
Arun Banpurkar
Superhydrophobic surfaces are widely used in various industrial and self-cleaning applications. Here, we present a low cost, facile synthesis of UV-resistant copper based superhydrophobic (SH) surface. The copper is electrochemically deposited on an another copper foil at the room temperature. The electrochemical bath consists of an aqueous solution of CuSO4 and H2SO4 acid. The samples were rinsed in ethanol and dried in a vacuum oven at 100 °C. The substrates were dip coated using 1 % Teflon AF solution to lower the surface energy. Also, another batch of copper surfaces was treated in stearic acid solution for hydrophobic coating. Both, the stearate and the Teflon coated copper surfaces shows hierarchical micro-nano surface morphology. The wetting properties on both the surfaces were extensively tested by static contact angle analysis, contact angle hysteresis (CAH) and droplet bouncing and rolling. Both the surfaces show, the average contact angle is about 165° and CAH is about 4°. The stability of the SH coating is tested against exposure to the ultraviolet (UV) A, B and C radiations. The Teflon AF coated surface retains SH property even after 2 hrs of UV exposure, whereas the stearate coating shows degradation in merely 30 min of exposure. Thus, the Teflon coated copper rough surface has potential in outdoor SH applications.

1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
ABArwa Bohra
Arwa Bohra
SAShubham Atal
Shubham Atal
AAAbhishek Anand
Abhishek Anand
SGSagar Goyal
Sagar Goyal
RJRajnish Joshi
Rajnish Joshi
AKAnurag Kanase
Anurag Kanase
Background: SARS-CoV-2 Virus can trigger severe pneumonia and lead to acute respiratory distress syndrome. Data from clinical, in vitro, and in vivo suggest that virus-induced cytokine dysregulation is a contributory factor to the pathogenesis. Drugs targeting the same are being tried. Methods: To obtain a better understanding of the molecular events, we studied the transcriptome of infected macrophages and obtained a list of incriminated pathways using Gene Set Enrichment Analysis. Co-expression gene analysis was further used to predict drug targets. Results: COVID-19 is characterized by a dysregulation of not only immune pathways, but of hemostasis, intercellular signaling, endothelium, cellular protein metabolism, trans-cellular transport and neuronal activity. Interferon alpha, beta, and gamma are upregulated. IL-1,4, 6,10, 12 13, TNF, NF-KB are upregulated. Signaling by NOTCH, and MAP kinase-6, 4 signaling are increased. Olfactory sensation, transmission across chemical synapses, and sperm motility appear to be downregulated. Disease host signature has some resemblance with cystic fibrosis, SARS infection, and diseases of programmed cell death like neurodegenerative diseases. 24 drugs are predicted including Sulindac, Pancuronium, Etamsylate, Ciclosporin, Ciprofloxacin, Valproic Acid, Triamcinolone, Tanespimycin, Tretinoin, Monorden, Scopolamine, Captopril, and Thalidomide. Conclusions: The effectiveness of this approach is demonstrated by the current level of evidence in understanding of COVID-19 pathophysiology. Several drugs of the same drug class have been used in COVID-19 treatment as predicted through the analysis. Further biomarker studies, drug testing on COVID infected cell-lines, and clinical studies are required for validation of obtained results.